Similar Papers

Paper Title
Journal
Date
Author
Chapter 4: Chemotherapy and radiotherapy
-
Hepatology Research | VOL. 40
--
19 May 2010
Abstract 5167: Identification of inactivating mutations in stepwise hepatocarcinogenesis using next generation sequencer
Yutaka Midorikawa ... David Wheeler
Cancer Research | VOL. 74
Yutaka Midorikawa, et. al.Yutaka Midorikawa ... David Wheeler
30 Sep 2014
Abstract 3911: A positive feedback loop between TGF-β and SCF mediates TGF-β1 ligand overexpression in advanced hepatocellular carcinoma
Pingyu Zhang ... Jing Wang
Cancer Research | VOL. 75
Pingyu Zhang, et. al.Pingyu Zhang ... Jing Wang
01 Aug 2015
Abstract 4020: Genome-wide analysis of stepwise hepatocarcinogenesis using next generation sequencer.
Yutaka Midorikawa ... Margaret Morgan
Cancer Research | VOL. 73
Yutaka Midorikawa, et. al.Yutaka Midorikawa ... Margaret Morgan
15 Apr 2013
View more papers

More From: Chinese clinical oncology

Paper Title
Journal
Date
Author
Advancing therapeutic frontiers in urothelial carcinoma: targeted strategies and clinical implications.
Marcela G B Guimarães ... Daniel M Girardi
Chinese clinical oncology | VOL. 13
Marcela G B Guimarães, et. al.Marcela G B Guimarães ... Daniel M Girardi
01 Dec 2024
The feasibility of the deep hypothermal cryotherapy plus immune checkpoint inhibitor for treatment of severe malignant central airway obstruction.
Zhibing Luo ... Wujian Xu
Chinese clinical oncology | VOL. 13
Zhibing Luo, et. al.Zhibing Luo ... Wujian Xu
01 Dec 2024
Tumour plasticity and tumour microenvironment interactions as potential immunologic targets for pancreatic cancer treatment.
Xu Zhou ... John Neoptolemos
Chinese clinical oncology | VOL. 13
Xu Zhou, et. al.Xu Zhou ... John Neoptolemos
01 Dec 2024
The differences in the distribution characteristics and prognostic value of tumor-infiltrating T lymphocyte subsets between lung adenocarcinoma and lung squamous cell carcinoma.
Zhen Zhang ... Wenjie Dong
Chinese clinical oncology | VOL. 13
Zhen Zhang, et. al.Zhen Zhang ... Wenjie Dong
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.